Suggestions
Brian Feth
Chief Executive Officer at Xcell Biosciences, Inc.
Brian Feth is the Chief Executive Officer and Founder of Xcell Biosciences, a San Francisco-based company focused on advancing cell and gene therapy applications. Under his leadership since 2012, Xcell Biosciences has developed innovative precision research and manufacturing platforms aimed at addressing significant unmet needs in immunotherapy and cell therapy drug screening.12
Background and Education
Feth's career in life sciences began with a strong educational foundation. He earned an MBA from the University of California, Berkeley, where he also co-founded Xcell Biosciences with Dr. James Lim. His early experiences included roles in management consulting and business development within the life sciences sector, notably at Novartis and L.E.K. Consulting.13
Professional Experience
- Xcell Biosciences (2012 - Present): As CEO, Feth has been instrumental in driving the company's mission to enhance the performance and safety of cell therapies through innovative technology platforms. The company has gained recognition for its AVATAR technology, which improves the potency and persistence of cell therapies.24
- Novartis (2012): Worked in global commercialization for less than a year.
- Strategyn Equity Partners (2010 - 2011): Engaged in life sciences investment strategies.
- TechnoServe (2009 - 2010): Managed projects in Africa, contributing to his interest in entrepreneurship.13
Vision and Impact
Feth's vision for Xcell Biosciences is rooted in his personal experiences with cancer, which have shaped his commitment to transformative change in healthcare. He emphasizes the importance of immune effector cells in targeting tumors effectively, a focus that has guided the company's research and development efforts.34
Xcell Biosciences continues to expand its influence in the biotech sector, recently announcing collaborations aimed at enhancing clinical-scale manufacturing processes for cell therapies.24
